Neuronetics, Inc.·4

May 29, 5:04 PM ET

Cucuz Sasha 4

Research Summary

AI-generated summary

Updated

Neuronetics (STIM) Director Sasha Cucuz Receives RSU Award

What Happened
Director Sasha Cucuz received a grant of 30,000 restricted stock units (RSUs) on 2026-05-28. The Form 4 reports the acquisition price as $0.00 (code A — award/grant); the RSUs are a contingent right to receive shares if and when they vest.

Key Details

  • Transaction date: 2026-05-28; Form 4 filed 2026-05-29 (appears timely).
  • Reported transaction: 30,000 RSUs granted at $0.00 (award, code A).
  • Shares owned after transaction: Not specified in the filing.
  • Footnotes from the filing:
    • F1: RSUs vest on the earlier of (a) May 28, 2027, or (b) the Reporting Person’s Board‑approved separation of service or a change in control, subject to continuous service.
    • F2: Each RSU represents a contingent right to one share of common stock upon vesting.
    • F3: The reporting person disclaims beneficial ownership except to the extent of pecuniary interest.
  • No 10b5-1 plan, tax‑withholding, or late‑filing flag reported.

Context
RSUs are compensation awards, not open‑market purchases; they convert into actual shares only if/when they vest, so they do not represent immediate buying pressure. For investors, grants signal how the company compensates executives or directors, but they are routine and do not, by themselves, indicate the insider is increasing or decreasing a personal stock stake.